erlotinib krka
krka, d.d., novo mesto - erlotinibas - plėvele dengtos tabletės - 150 mg - erlotinib
isotretinoin sandoz
sandoz d.d. - izotretinoinas - minkštosios kapsulės - 5 mg - isotretinoin
isotretinoin sandoz
sandoz d.d. - izotretinoinas - minkštosios kapsulės - 10 mg - isotretinoin
isotretinoin sandoz
sandoz d.d. - izotretinoinas - minkštosios kapsulės - 20 mg - isotretinoin
roaccutane
lex ano, uab - izotretinoinas - minkštosios kapsulės - 10 mg - isotretinoin
roaccutane
lex ano, uab - izotretinoinas - minkštosios kapsulės - 20 mg - isotretinoin
elzonris
stemline therapeutics b.v. - tagraxofusp - lymphoma - antinavikiniai vaistai - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).
isotretinoin bijon
bijon medica, uab - izotretinoinas - minkštosios kapsulės - 20 mg - isotretinoin
celsunax
pinax pharma gmbh - ioflupane (123i) - radionuclide imaging; dementia; movement disorders - diagnostikos radiofarmaciniai preparatai - Šis vaistas yra skirtas tik diagnostikai. celsunax is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. celsunax is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy. suaugusių pacientų, padėti atskirti tikėtina demencija su lewy įstaigos nuo alzheimerio ligos. celsunax is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.
adtralza
leo pharma a/s - tralokinumab - dermatitas, atopinis - kiti dermatologiniai preparatai - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.